Search alternatives:
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greatest decrease » greater decrease (Expand Search), treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1721
Pharmacokinetic characteristics of oseltamivir in CES1 c.662A>G and wild-type subjects.
Published 2017Subjects: -
1722
-
1723
ALS Variants of Annexin A11’s Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution
Published 2023Subjects: -
1724
-
1725
HoxA9 represses and C/EBPα activates the <i>Cebpa</i> +8 kb enhancer in immature myeloid cells.
Published 2019Subjects: -
1726
-
1727
-
1728
The <i>Cebpa</i> +8 kb enhancer is primed in HoxA9/Meis1-immortalized myeloid progenitors.
Published 2019Subjects: -
1729
-
1730
Reciprocal relation between <i>HoxA9</i> and <i>Cebpa</i> in hematopoietic progenitors.
Published 2019Subjects: -
1731
-
1732
-
1733
-
1734
-
1735
-
1736
Scatter plots with superimposed linear regression lines correlating logarithm of ADC with age in the basal ganglia.
Published 2018“…<p>a. Thalamus b. Caudate c. Putamen. There is a strong (R = -0.64 for Thalamus, R = -0.63 for Caudate, R = -0.65 for Putamen) and significant (with a p-value <10<sup>−4</sup>) decrease in ADC with respect to age.…”
-
1737
-
1738
-
1739
-
1740